Department of Defense Global Laboratory-Based Influenza Surveillance. 1998-2005

American Journal of Preventive Medicine

Volumn 37, Issue 3, 2009, Pages 235-241

  Owens, Angela B ^a   Canas, Linda C ^a   Russell, Kevin L ^b   Neville, James S ^a   Pavlin, Julie A ^c   MacIntosh, Victor H ^a   Gray, Gregory C ^d   Gaydos, Joel C ^b  

^a Brooks City Base ^*  (United States)

^b Armed Forces Health Surveillance Center   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ENTEROVIRUS; EPIDEMIC; HERPES SIMPLEX VIRUS; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN; PARAINFLUENZA VIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SEASON; VIRUS ISOLATION;

CLINICAL LABORATORY INFORMATION SYSTEMS; DATABASES, FACTUAL; HUMANS; INFLUENZA, HUMAN; LABORATORIES; MILITARY PERSONNEL; POPULATION SURVEILLANCE; SEASONS; UNITED STATES; WORLD HEALTH;

EID: 68149129566     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2009.04.022     Document Type: Review

References (24)

1. Gaydos J.C. The need for a military public health laboratory symposium. Mil Med 165 (2000) 5-7
2. In: Lederberg J., Shope R.E., and Oaks S.C. (Eds). Emerging infections: microbial threats to health in the United States (1992), National Academy Press, Washington DC
3. Committee on International Science, Engineering, and Technology, Working group on emerging and re-emerging infectious disease. Infectious disease a global threat: report of the National Science and Technology Council (1995), Committee on International Science, Engineering, and Technology, Washington DC
4. The White House Office of Science and Technology Policy. Addressing the threat of emerging infectious diseases. National Science and Technology Council Presidential Decision Directive (NSTC-7) (1996), The White House, Washington DC
5. Department of Defense Global Emerging Infections Surveillance and Response System. Addressing emerging infectious disease threats: a strategic plan for the Department of Defense (1998), Walter Reed Army Institute of Research, Washington DC
6. Bailey S. Policy for DoD global, laboratory-based influenza surveillance. HA Policy 99-008 (February 3, 1999), Office of the Assistance Secretary of Defense, Washington DC
7. CDC. Update: isolation of avian influenza A (H5N1) viruses from humans. Hong Kong, 1997-1998. MMWR 46 (1998) 1245-1247
8. Canas L.C., Lohman K., Pavlin J.A., et al. The Department of Defense laboratory-based global influenza surveillance system. Mil Med 165 S2 (2000) 52-56
9. Williams R.J., Cox N.J., Regnery H.L., et al. Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. Mil Med 162 (1997) 82-86
10. Gaydos J.C., Tin C.O., Parks S.D., et al. Influenza-U.S. Army medical facilities, Europe (International Notes). MMWR 29 (1980) 294-295
11. Gaydos C.A., and Gaydos J.C. Adenovirus vaccines in the U.S. Military. Mil Med 160 (1995) 300-304
12. Gray G.C., Callahan J.D., Hawksworth A.W., Fisher C.A., and Gaydos J.C. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis 5 (1999) 379-387
13. Gray G.C., Goswami P.R., Malasig M.D., et al. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. Clin Infect Dis 31 (2000) 663-670
14. Ryan M., Gray G., Hawksworth A., Malasig M., Hudspeth M., and Poddar S. The Naval Health Research Center Respiratory Disease Laboratory. Mil Med 165 S2 (2000) 32-34
15. Gambel J.M., and Hibbs R.G. U.S. Military overseas medical research laboratories. Mil Med 11 (1996) 638-645
16. Russell K.L., Ryan M.A.K., Hawksworth A.W., Freed N.E., Irvine M., Daum L.T., and NHRC Respiratory Disease Surveillance Team. Effectiveness of the 2003-04 influenza vaccine among U.S. Military basic trainees: a year of suboptimal match between vaccine and circulating strain. Vaccine 23 (2005) 1981-1985
17. CDC, NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL). 5th edition (2007), Government Printing Office, Washington DC
18. Daum L.T., Canas L.C., Arulanandam B.P., Niemeyer D., Valdes J.J., and Chambers J.P. Real-time RT-PCR assays for type and subtype detection of influenza A and B viruses. Influenza Other Respi Viruses 1 (2007) 167-175
19. WHO. Influenza reagent kit for identification of influenza isolates (1998), WHO Collaborating Center for Reference and Research on Influenza, Atlanta GA (updated annually)
20. CDC. Update: influenza activity-United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine. MMWR 49 (2000) 375-381
21. Daum L.T., Canas L.C., Smith C.B., et al. Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas. Emerg Infect Dis 8 (2002) 408-412
22. Daum L.T., Shaw M.W., Klimov A.I., et al. Influenza A (H3N2) outbreak, Nepal. Emerg Infect Dis 11 (2005) 1186-1191
23. DoD-GEIS. Annual report fiscal year (2004) 15
24. In: Neville J., and Kisilev O.I. (Eds). Strengthening influenza pandemic preparedness through civil-Military cooperation. Volume 360, NATO Science Series, I: Life and Behavioural Sciences (2004), IOS Press